Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile-Reference-Cited by-同舟云学术

Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile

Published:2024-04-03 Issue:4 Volume:7 Page:2582-2593
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Madani Aqilah F.¹,Syauqi Muhammad A.¹,Permatasari Jihan A.¹,Putri Annisa A.¹,M Fadel²,Permana Andi Dian¹^ORCID

Affiliation:

1. Faculty of Pharmacy, Hasanuddin University, Makassar 90245, South Sulawesi, Indonesia

2. Faculty of Medicine, Hasanuddin University, Makassar 90245, South Sulawesi, Indonesia

Funder

Kementerian Pendidikan, Kebudayaan, Riset, dan Teknologi

Universitas Hasanuddin

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00246

Reference54 articles.

1. Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats

2. Detecting Alzheimer’s Disease by The Decision Tree Methods Based On Particle Swarm Optimization

3. Population‐based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans

4. Underweight Nutritional Status as a Predictor of Mortality in Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microneedle-mediated drug delivery for neurological diseases;International Journal of Pharmaceutics;2024-08